期刊文献+

BNP与六分钟步行试验评估慢性心力衰竭患者心功能的价值 被引量:6

在线阅读 下载PDF
导出
摘要 目的探讨血浆脑钠肽(BNP)和六分钟步行试验评估慢性心力衰竭患者心功能的价值。方法慢性心力衰竭195例,根据NYHA心功能分级分为两组,1组(心功能Ⅰ/Ⅱ级)164例,2组(心功能Ⅲ级)31例。测定血浆BNP并进行六分钟步行试验。结果慢性心力衰竭患者血浆BNP水平与心功能分级呈显著正相关(r=0.58,P<0.01);六分钟步行距离,最大耗氧量和最大耗氧量标准值与心功能分级呈显著负相关(r=-0.61、-0.42和-0.43,均P<0.01)。经ROC曲线分析,用BNP预测心功能Ⅰ/Ⅱ级患者的曲线下面积为0.81,95%CI为0.75-0.88,预测心功能Ⅲ级患者的曲线下面积为0.66,95%CI为0.54-0.77。六分钟步行试验距离,最大耗氧量,最大耗氧量标准值预测心功能Ⅰ/Ⅱ级患者的曲线下面积为0.18、0.28、0.27,95%CI为0.12-0.25、0.20-0.36、0.18-0.35,预测心功能Ⅲ级患者的曲线下面积为0.26、0.37、0.38,95%CI为0.45-0.82、0.27-0.48、0.27-0.49。结论在心功能Ⅰ/Ⅱ级患者中,血浆BNP评估心功能的价值明显优于六分钟步行试验。而在心功能Ⅲ级患者中,血浆BNP和六分钟步行试验评估心功能的价值相似。
出处 《心脑血管病防治》 2011年第2期114-117,共4页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
作者简介 吕晓春(1985-),女,在读硕士生,从事ICU工作
  • 相关文献

参考文献13

  • 1Maisel AS,Krishnaswamy P,Nowak PM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J].N Engl J Med,2002,347(3):161-167.
  • 2张慧平,孙福成.B型利钠肽与心力衰竭[J].中华老年医学杂志,2005,24(10):790-793. 被引量:17
  • 3Richards AM,Doughty R,Nicholls MG,et al.Plasma N'terminal pro-brain natriuretic peptide and adrenomedullin:prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction[J].J Am Coll Cardiol,2001,37(7):1781-1787.
  • 4Guyatt GH,Sullivan MJ,Thompson PJ,et al.The 6-minute walk:a new measure of exercise capacity in patients with chronic heart failure[J].Can Med Assoc J,1985,132(8):919-923.
  • 5Armstrong P W,Moe G W.Medical advances in the therapy of chronic heart failure[J].Circulation,1993,88(6):2941-2952.
  • 6Bitter V,Weiner DH,Yusuf S,et al.Prediction of mortality and morbidity with a 6-minutew walk test in patients with left ventricular dysfunction[J].JAMA,1993,270(14):1702-1707.
  • 7Lipkin D P,Scriven A J,Crake T,et al.Six minute walking test for assessing exercise capacity in chronic heart failure[J].Br Med J,1986,292:653-655.
  • 8Cahalin L P,Pappagianopoulos P,Prevosr S,et al.The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease[J].Chest,1995,108(2):452-459.
  • 9Butland R J A,Pang J,Gross E R,et al.Two-,Six-,and 12-minutes walking tests in respiratory disease[J].Br Med J,1982,284:1607-1608.
  • 10Riley M,Mcparland J,Stanford C F,et al.Oxygen consumption during corridor walk teating in chronic cardiac failure[J].EUR Heart J,1992,13(6):789-793.

二级参考文献32

  • 1Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 1997, 96:509-516.
  • 2Adams KF , Mathur VS, Gheorghiade M. B-type natriuretic peptide: from bench to bedside. Am Heart J, 2003, 145:S34-46.
  • 3Chen HH, Burnett JC. The natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep, 2000, 3:198-205.
  • 4Christian H. Essential biochemistry and physiology of (NT-pro)BNP. EurJ Heart Fail, 2004, 6:257-260.
  • 5Wu A, Smith A. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. EurJ Heart Fail, 2004, 6:355-358.
  • 6Hystad ME, Geiran OR, Attramadal H, et al.Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand, 2001, 171 :395-403.
  • 7Magga J, Marttila M, Mantymaa P, et al. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats.Endocrinology, 1994, 134:2505-2515.
  • 8Harada M, Saito Y, Kuwahara K, et al. Interaction of myocytes and non-myocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. J Cardiovasc Pharmacol, 1998, 31(suppl 1):S357-359.
  • 9Thuerauf DJ, Glembotski CC. Differential effects of protein kinase C, ras, and raf-1 kinase on the induction of the cardiac B-type natriuretic peptide gene through a critical promoter-proximal MCAT element. J Biol Chem, 1997, 272:7464-7472.
  • 10Ambrose TM. A review of the clinical utility of NT-pro BNP in the diagnosis, prognosis, and therapy monitoring of patients with congestive heart failure. J Clin Ligand Assay, 2003, 25:160-166.

共引文献16

同被引文献30

引证文献6

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部